The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate-Placebo Randomized Controlled Trial.

Icon for Springer Related Articles

The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate-Placebo Randomized Controlled Trial.

Child Psychiatry Hum Dev. 2020 Apr 27;:

Authors: Hadar Y, Hocherman S, Lamm O, Tirosh E

Abstract
To assess the visuomotor attention ability in children with ADHD and controls and their response to placebo and Methylphenidate (MPH) treatment. 36 boys with ADHD and 36 age matched typical controls were administered the visuomotor attention test (VMAT) as a baseline and following a week of MPH(IR) or placebo administered to the study group, in a randomized crossover design. A significant difference between the study and control groups was found on several VMAT measures. No performance difference between ADHD dimensional sub-types was observed at the baseline assessment. Under MPH treatment a significant improvement in VMAT measures was observed and particularly in the combined and predominantly hyperactive (C\HI) type. The VMAT results obtained in the present study are consistent with previous findings. ADHD subtypes appear similarly short of visuomotor attention resources; a visuomotor test can be used in the assessment of gains derived from MPH treatment.

PMID: 32342235 [PubMed – as supplied by publisher]

via https://www.ncbi.nlm.nih.gov/pubmed/32342235?dopt=Abstract